BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coleman OI, Haller D. Microbe-Mucus Interface in the Pathogenesis of Colorectal Cancer. Cancers (Basel) 2021;13:616. [PMID: 33557139 DOI: 10.3390/cancers13040616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lama Tamang R, Juritsch AF, Ahmad R, Salomon JD, Dhawan P, Ramer-tait AE, Singh AB. The diet-microbiota axis: a key regulator of intestinal permeability in human health and disease. Tissue Barriers. [DOI: 10.1080/21688370.2022.2077069] [Reference Citation Analysis]
2 Jiang X, Jiang Z, Jiang M, Sun Y. Berberine as a Potential Agent for the Treatment of Colorectal Cancer. Front Med 2022;9:886996. [DOI: 10.3389/fmed.2022.886996] [Reference Citation Analysis]
3 Tsiaoussis J, Souglakos J. Microbiota: An Emerging Biomarker in Colorectal Cancer. Cancers (Basel) 2021;13:5530. [PMID: 34771692 DOI: 10.3390/cancers13215530] [Reference Citation Analysis]
4 Angus HC, Urbano PC, Laws GA, Fan S, Gadeock S, Schultz M, Butt G, Highton AJ, Kemp RA. An autologous colonic organoid‐derived monolayer model to study immune: bacterial interactions in Crohn's disease patients. Clin & Trans Imm 2022;11. [DOI: 10.1002/cti2.1407] [Reference Citation Analysis]
5 Galindo-Pumariño C, Collado M, Herrera M, Peña C. Tumor Microenvironment in Metastatic Colorectal Cancer: The Arbitrator in Patients' Outcome. Cancers (Basel) 2021;13:1130. [PMID: 33800796 DOI: 10.3390/cancers13051130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Watchorn J, Clasky AJ, Prakash G, Johnston IAE, Chen PZ, Gu FX. Untangling Mucosal Drug Delivery: Engineering, Designing, and Testing Nanoparticles to Overcome the Mucus Barrier. ACS Biomater Sci Eng 2022;8:1396-426. [PMID: 35294187 DOI: 10.1021/acsbiomaterials.2c00047] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]